离散选择实验的发展:在新西兰调查药房选择
James Nind1, Carlo A Marra1, Shane Scahill2
1School of Pharmacy, University of Otago, Dunedin, New Zealand.
Health policy (Amsterdam, Netherlands)
|January 23, 2025
概括
这项研究开发了一个离散选择实验 (DCE),以了解新西兰人对社区药房的偏好. 影响选择的关键因素包括位置,等待时间和客户服务.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 消费者行为分析分析
背景情况:
- 离散选择实验 (DCE) 对于了解服务偏好是有价值的.
- 有限的研究存在于DCE应用程序的社区药房选择.
- 属性和级别的选择对DCE的有效性和准确性至关重要.
研究的目的:
- 描述DCE的发展,用于调查新西兰人对社区药房的偏好.
- 确定影响社区药房选择的关键属性.
主要方法:
- 在不同的人口群体进行了五个重点小组.
- 采用转录的专题分析来识别关键属性.
- 开发和试点测试了一项调查,其中包括选择任务和人口统计问题.
主要成果:
- 确定了六个属性:位置,等待时间,客户服务,处方支付,附近的企业和停车场.
- 属性是作为参与者在线信息的框架.
- 焦点小组为选择现实的和重要的属性提供了信息.
结论:
- 对DCE属性开发的详细报告增强了对方法有效性的评估.
- 确定了影响新西兰社区药房选择的特定因素.
- 这种方法为未来的偏好研究提供了坚实的框架.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Analysis of Population Pharmacokinetic Data
222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222
Quantitative Aspects of Drug-Receptor Interaction
931
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
931
Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K


